Curr Oncol. 2025 Oct 31;32(11):608. doi: 10.3390/curroncol32110608.ABSTRACTMalignant hilar biliary obstruction (MHBO) is a complex clinical condition commonly observed in individuals with advanced cholangiocarcinoma and other hepatobiliary malignancies. Endoscopic stenting remains the primary palliative intervention for unresectable cases; however, the optimal strategy has not been clearly defined owing to the anatomical intricacies of the hilar region and the heterogeneity of disease presentation. This narrative review summarizes current evidence and ongoing debates on functional liver volume-based drainage, unilateral versus bilateral stenting, stent type selection, and above-the-papilla approaches. In addition, we highlight recent progress in endoscopic ultrasound-guided biliary drainage as a promising alternative…
Origen: Endoscopic Stenting for Unresectable Malignant Hilar Biliary Obstruction: Where Do We Stand Today? A Narrative Review – PubMed

J Manag Care Spec Pharm. 2025 Dec;31(12):1244-1247. doi: 10.18553/jmcp.2025.31.12.1244.ABSTRACTBACKGROUND: In 2016, the Safe & Effective Management of Pain (SEMP) organization created guidelines regarding how to safely and effectively ensure patients were being treated with opioids. Two insurance companies in West Virginia used the SEMP guidelines to create a prior authorization (PA) form. This form requires extensive information about the patient to be submitted and then reviewed, including those with cancer or being treated with palliative intent.OBJECTIVE: To evaluate the potential delay in accessing opioid prescriptions for patients with cancer or in palliative care who are required to use a specific…
Origen: Evaluating time to access opioid treatment for patients with insurance that requires the Safe & Effective Management of Pain prior authorization form vs others – PubMed

Breast. 2025 Dec;84:104604. doi: 10.1016/j.breast.2025.104604. Epub 2025 Oct 14.ABSTRACTAdvanced breast cancer (ABC) represents a significant global health challenge, not only due to its high mortality rates but also because of the profound physical, emotional, and social burden it imposes on patients. Support services – encompassing psychological, social and peer support, complementary and integrative therapies, wellness and lifestyle support, genetic counseling, survivorship programs, palliative and end-of-life care – are essential to addressing these challenges and ensuring that individuals with ABC receive holistic, person-centered care throughout their disease journey. This manuscript outlines the need for universal access to comprehensive, tailored support services…
Origen: Increasing awareness of and referral to support services in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 7) – PubMed

Am J Manag Care. 2025 Nov;31(11):656-663. doi: 10.37765/ajmc.2025.89817.ABSTRACTOBJECTIVES: Community-based palliative care provides support for community-dwelling individuals with elevated mortality risk, including those with dementia, who are underserved by palliative care. However, clinicians’ eligibility assessment processes are not well understood. This study evaluates the relationship between the factors that clinicians indicate are important and the eligibility determinations for a community-based palliative care program.STUDY DESIGN: Retrospective cohort analysis of July 2022 to December 2023 Medicare administrative claims data for a Medicare Advantage plan offering community-based palliative care. Participants included all members of the Medicare Advantage insurance plan who were identified as being…
Origen: Clinician-identified health characteristics and palliative care eligibility: is dementia overlooked? – PubMed

Support Care Cancer. 2025 Nov 25;33(12):1133. doi: 10.1007/s00520-025-10211-7.ABSTRACTPURPOSE: Patients with advanced cancer experience progressive deterioration in symptom burden, activities of daily living (ADLs), and self-efficacy as they approach the end of life. This pilot longitudinal study aimed to examine the trajectories of these indicators in a palliative care setting and to identify factors associated with survival time.METHODS: We conducted a prospective observational study of 70 patients with advanced cancer admitted to an acute palliative care unit (APCU) between November 2019 and March 2022. Outcomes included symptom burden, ADLs, and self-efficacy. Scores were reported by the patients or providers during admissions…
Origen: Distinctive trajectories of symptom burden, activities of daily living, and self-efficacy among patients with advanced cancer receiving care in an acute palliative care unit: a pilot longitudinal study – PubMed